Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib As a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models.Caitlin D. Lowery,Michele Dowless,Matthew Renschler,Wayne Blosser,Alle B. VanWye,Jennifer R. Stephens,Philip W. Iversen,Aimee Bence Lin,Richard P. Beckmann,Kateryna Krytska,Kristina A. Cole,John M. Maris,Douglas S. Hawkins,Brian P. Rubin,Raushan T. Kurmasheva,Peter J. Houghton,Richard Gorlick,E. Anders Kolb,Min H. Kang,C. Patrick Reynolds,Stephen W. Erickson,Beverly A. Teicher,Malcolm A. Smith,Louis F. StancatoClinical Cancer Research（2018）引用 61|浏览77关键词DNAAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
